In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 64 for your search:
Cancer Type/Condition:  Neuroblastoma
Country:  U.S.A.
Trial Type:  Treatment
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 30 and under at diagnosis
Sponsor: NCI
Protocol IDs: NCI-2009-01064, CDR0000069018, COG-ANBL0032, ANBL0032, U10CA098543, COG-P9842, NCT00026312

2.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 1 to 25
Sponsor: NCI, Other
Protocol IDs: 2013-062, NCI-2013-02001, P30CA022453, NCT01987596

3.

Phase: Phase III
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 17 months and under
Sponsor: NCI, Other
Protocol IDs: ANBL1232, NCI-2014-00677, U10CA098543, U10CA180886, NCT02176967

4.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: ECP RIT, NCT00179790

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: 05-075, NCT00911560

6.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI, Other
Protocol IDs: ADVL0912, COG-ADVL0912, CDR0000647587, NCT00939770

7.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 4 to 21
Sponsor: Other
Protocol IDs: 10-096, NCT01294670

8.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Over 12 months to 30 years
Sponsor: Pharmaceutical / Industry
Protocol IDs: NMTRC 004, NCT01483820

9.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 12 to 21
Sponsor: Other
Protocol IDs: NMTRC 005, NCT01505608

10.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 6 months to 21 years
Sponsor: Pharmaceutical / Industry
Protocol IDs: ABI-007-PST-001, NCT01962103

11.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 1 to 21
Sponsor: NCI
Protocol IDs: NCI-2014-00547, ADVL1312, UM1CA097452, NCT02095132

12.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: NMTRC010, NCT02139397

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: Under 75
Sponsor: NCI, Other
Protocol IDs: 1825.00, NCI-2010-00230, P30CA015704, P01CA078902, FHCRC-1825.00, 5605, SUPERGEN-FHCRC-1825.00, NCT00096161

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: Over 1
Sponsor: NCI, Other
Protocol IDs: 04-148, MSKCC-04148, NCT00107289

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 years and under
Sponsor: Other
Protocol IDs: IRB# 0405652, NCT00202930

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 05-122, MSKCC-05122, NCT00445965

17.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: V0706, NCT00601003

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: Not specified
Sponsor: Other
Protocol IDs: 2007LS072, UMN-MT2007-07, 0707M11845, UMN-2007LS072, NCT00617929

19.

Phase: Phase II
Type: Treatment
Status: Active
Age: Any age
Sponsor: Other
Protocol IDs: 10-015, NCT01114555

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 months and over
Sponsor: Other
Protocol IDs: 09-159, NCT01183429

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 months and over
Sponsor: Other
Protocol IDs: 09-160, NCT01183884

22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 months and over
Sponsor: Other
Protocol IDs: 09-161, NCT01183897

23.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 0 to 21
Sponsor: Other
Protocol IDs: 11-183, NCT01492673

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Pharmaceutical / Industry
Protocol IDs: NMTRC 003, NCT01586260

25.

Phase: Phase II
Type: Treatment
Status: Active
Age: Children
Sponsor: NCI
Protocol IDs: NCI-2012-03125, COG-ANBL1221, CDR0000745188, ANBL1221, U10CA180886, U10CA098543, NCT01767194
1    
New Search